FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2463183688> ?p ?o ?g. }

• W2463183688 endingPage "2842" @default.
• W2463183688 startingPage "2835" @default.
• W2463183688 abstract "Purpose There is growing interest in the role of local therapies, including external beam radiotherapy (RT), for men with metastatic prostate cancer (mPCa). We used the National Cancer Database (NCDB) to evaluate the overall survival (OS) of men with mPCa treated with androgen deprivation (ADT) with and without prostate RT. Methods The NCDB was queried for men with newly diagnosed mPCa, all treated with ADT, with complete datasets for RT, surgery, prostate-specific antigen (PSA) level, Gleason score, and Charlson-Deyo comorbidity score. OS was analyzed using the Kaplan-Meier method, log-rank test, Cox proportional hazards models, and propensity score-matched analyses. Results From 2004 to 2012, 6,382 men with mPCa were identified, including 538 (8.4%) receiving prostate RT. At a median follow-up of 5.1 years, the addition of prostate RT to ADT was associated with improved OS on univariate (P < .001) and multivariate analysis (hazard ratio, 0.624; 95% CI, 0.551 to 0.706; P < .001) adjusted for age, year, race, comorbidity score, PSA level, Gleason score, T stage, N stage, chemotherapy administration, treating facility, and insurance status. Propensity score analysis with matched baseline characteristics demonstrated superior median (55 v 37 months) and 5-year OS (49% v 33%) with prostate RT plus ADT compared with ADT alone (P < .001). Landmark analyses limited to long-term survivors of ≥1, ≥3, and ≥5 years demonstrated improved OS with prostate RT in all subsets (all P < .05). Secondary analyses comparing the survival outcomes for patients treated with therapeutic dose RT plus ADT versus prostatectomy plus ADT during the same time interval demonstrated no significant differences in OS, whereas both therapies were superior to ADT alone. Conclusion In this large contemporary analysis, men with mPCa receiving prostate RT and ADT lived substantially longer than men treated with ADT alone. Prospective trials evaluating local therapies for mPCa are warranted." @default.
• W2463183688 created "2016-07-22" @default.
• W2463183688 creator A5001600608 @default.
• W2463183688 creator A5011724315 @default.
• W2463183688 creator A5022467705 @default.
• W2463183688 creator A5041112113 @default.
• W2463183688 creator A5046609076 @default.
• W2463183688 creator A5051028960 @default.
• W2463183688 creator A5052966036 @default.
• W2463183688 creator A5078699439 @default.
• W2463183688 creator A5081777867 @default.
• W2463183688 creator A5088312939 @default.
• W2463183688 creator A5090748784 @default.
• W2463183688 date "2016-08-20" @default.
• W2463183688 modified "2023-10-18" @default.
• W2463183688 title "Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer" @default.
• W2463183688 cites W1861186132 @default.
• W2463183688 cites W1971211622 @default.
• W2463183688 cites W2001933720 @default.
• W2463183688 cites W2004079062 @default.
• W2463183688 cites W2021256410 @default.
• W2463183688 cites W2034978466 @default.
• W2463183688 cites W2042540623 @default.
• W2463183688 cites W2049136550 @default.
• W2463183688 cites W2067125737 @default.
• W2463183688 cites W2090568575 @default.
• W2463183688 cites W2102032555 @default.
• W2463183688 cites W2105647806 @default.
• W2463183688 cites W2111635289 @default.
• W2463183688 cites W2114853434 @default.
• W2463183688 cites W2114932214 @default.
• W2463183688 cites W2116340214 @default.
• W2463183688 cites W2116661424 @default.
• W2463183688 cites W2117511763 @default.
• W2463183688 cites W2121759717 @default.
• W2463183688 cites W2126706478 @default.
• W2463183688 cites W2134925906 @default.
• W2463183688 cites W2137974207 @default.
• W2463183688 cites W2146530991 @default.
• W2463183688 cites W2146599397 @default.
• W2463183688 cites W2147509995 @default.
• W2463183688 cites W2150865892 @default.
• W2463183688 cites W2161587504 @default.
• W2463183688 cites W2214621962 @default.
• W2463183688 cites W2252704011 @default.
• W2463183688 cites W2408946761 @default.
• W2463183688 cites W4319718291 @default.
• W2463183688 cites W86137910 @default.
• W2463183688 doi "https://doi.org/10.1200/jco.2016.67.4788" @default.
• W2463183688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27325855" @default.
• W2463183688 hasPublicationYear "2016" @default.
• W2463183688 type Work @default.
• W2463183688 sameAs 2463183688 @default.
• W2463183688 citedByCount "190" @default.
• W2463183688 countsByYear W24631836882016 @default.
• W2463183688 countsByYear W24631836882017 @default.
• W2463183688 countsByYear W24631836882018 @default.
• W2463183688 countsByYear W24631836882019 @default.
• W2463183688 countsByYear W24631836882020 @default.
• W2463183688 countsByYear W24631836882021 @default.
• W2463183688 countsByYear W24631836882022 @default.
• W2463183688 countsByYear W24631836882023 @default.
• W2463183688 crossrefType "journal-article" @default.
• W2463183688 hasAuthorship W2463183688A5001600608 @default.
• W2463183688 hasAuthorship W2463183688A5011724315 @default.
• W2463183688 hasAuthorship W2463183688A5022467705 @default.
• W2463183688 hasAuthorship W2463183688A5041112113 @default.
• W2463183688 hasAuthorship W2463183688A5046609076 @default.
• W2463183688 hasAuthorship W2463183688A5051028960 @default.
• W2463183688 hasAuthorship W2463183688A5052966036 @default.
• W2463183688 hasAuthorship W2463183688A5078699439 @default.
• W2463183688 hasAuthorship W2463183688A5081777867 @default.
• W2463183688 hasAuthorship W2463183688A5088312939 @default.
• W2463183688 hasAuthorship W2463183688A5090748784 @default.
• W2463183688 hasConcept C10515644 @default.
• W2463183688 hasConcept C121608353 @default.
• W2463183688 hasConcept C126322002 @default.
• W2463183688 hasConcept C126894567 @default.
• W2463183688 hasConcept C143998085 @default.
• W2463183688 hasConcept C17923572 @default.
• W2463183688 hasConcept C207103383 @default.
• W2463183688 hasConcept C2776235491 @default.
• W2463183688 hasConcept C2777899217 @default.
• W2463183688 hasConcept C2779159551 @default.
• W2463183688 hasConcept C2780192828 @default.
• W2463183688 hasConcept C2781406297 @default.
• W2463183688 hasConcept C44249647 @default.
• W2463183688 hasConcept C50382708 @default.
• W2463183688 hasConcept C509974204 @default.
• W2463183688 hasConcept C71924100 @default.
• W2463183688 hasConcept C72563966 @default.
• W2463183688 hasConceptScore W2463183688C10515644 @default.
• W2463183688 hasConceptScore W2463183688C121608353 @default.
• W2463183688 hasConceptScore W2463183688C126322002 @default.
• W2463183688 hasConceptScore W2463183688C126894567 @default.
• W2463183688 hasConceptScore W2463183688C143998085 @default.
• W2463183688 hasConceptScore W2463183688C17923572 @default.
• W2463183688 hasConceptScore W2463183688C207103383 @default.

• next